APA

Swami S., Zhao X., Sarabia S., Siu-Caldera M., Uskokovic M., Reddy S. G. & Feldman D. (20031204). A low-calcemic vitamin D analog (Ro 25-4020) inhibits the growth of LNCaP human prostate cancer cells with increased potency by producing an active 24-oxo metabolite (Ro 29-9970). : Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Chicago

Swami Srilatha, Zhao Xian-Yan, Sarabia Stephen, Siu-Caldera Mei-Lung, Uskokovic Milan, Reddy Satya G and Feldman David. 20031204. A low-calcemic vitamin D analog (Ro 25-4020) inhibits the growth of LNCaP human prostate cancer cells with increased potency by producing an active 24-oxo metabolite (Ro 29-9970). : Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Harvard

Swami S., Zhao X., Sarabia S., Siu-Caldera M., Uskokovic M., Reddy S. G. and Feldman D. (20031204). A low-calcemic vitamin D analog (Ro 25-4020) inhibits the growth of LNCaP human prostate cancer cells with increased potency by producing an active 24-oxo metabolite (Ro 29-9970). : Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

MLA

Swami Srilatha, Zhao Xian-Yan, Sarabia Stephen, Siu-Caldera Mei-Lung, Uskokovic Milan, Reddy Satya G and Feldman David. A low-calcemic vitamin D analog (Ro 25-4020) inhibits the growth of LNCaP human prostate cancer cells with increased potency by producing an active 24-oxo metabolite (Ro 29-9970). : Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. 20031204.